Liver parenchyma heterogeneity in the response to extracellular NAD+.
The perfused rat liver responds intensely to NAD+ infusion (20-100 microM). Increases in portal perfusion pressure and glycogenolysis and transient inhibition of oxygen consumption are some of the effects that were observed. The aim of the present work was to investigate the distribution of the response to extracellular NAD+ along the hepatic acinus. The bivascularly perfused rat liver was used. Various combinations of perfusion directions (antegrade and retrograde) and infusion routes (portal vein, hepatic vein and hepatic artery) were used in order to supply NAD+ to different regions of the liver parenchyma, also taking advantage of the fact that its extracellular transformation generates steep concentration gradients. Oxygen uptake was stimulated by NAD+ in retrograde perfusion (irrespective of the infusion route) and transiently inhibited in antegrade perfusion. This indicates that the signal causing oxygen uptake inhibition is generated in the periportal area. The signal responsible for oxygen uptake stimulation is homogenously distributed. Stimulation of glucose release was more intense when NAD+ was infused into the portal vein or into the hepatic artery, indicating that stimulation of glycogenolysis predominates in the periportal area. The increases in perfusion pressure were more pronounced when the periportal area was supplied with NAD+ suggesting that the vasoconstrictive elements responding to NAD+ predominate in this region. The response to extracellular NAD+ is thus unequally distributed in the liver. As a paracrine agent, NAD+ is likely to be released locally. It can be concluded that its effects will be different depending on the area where it is released.
Gimenes
Daniele
D
Laboratory of Liver Metabolism, University of Maringá, 87020900 Maringá, Brazil.
Constantin
Jorgete
J
Comar
Jurandir Fernando
JF
Kelmer-Bracht
Ana Maria
AM
Broetto-Biazon
Ana Carla
AC
Bracht
Adelar
A
D000818:Animals; D005947:Glucose / Q000378:metabolism*; D050261:Glycogenolysis / Q000187:drug effects; D006019:Glycolysis / Q000502:physiology; D006439:Hemodynamics / Q000187:drug effects; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008112:Liver Glycogen / Q000378:metabolism*; D008297:Male; D009243:NAD / Q000378:metabolism* / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects / Q000502:physiology; D019899:Paracrine Communication; D010477:Perfusion / Q000379:methods; D051381:Rats; D017208:Rats, Wistar
D008112:Liver Glycogen; D009243:NAD; D005947:Glucose